Brief: Cancer Genetics Filed Prospectus Supplement Related To Offering Of Up To $2.4 Million Of Common Stock
Dec 3 (Reuters) - Cancer Genetics Inc CGIX.O :
* CANCER GENETICS FILED PROSPECTUS SUPPLEMENT RELATED TO
OFFERING
OF UP TO $2.4 MILLION OF COMMON STOCK - SEC FILING
Source text for Eikon: [ID:https://bit.ly/3mAqasp]
Further company coverage: CGIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration